PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate (IMAGE)
Caption
PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate
Credit
polyu
Usage Restrictions
nil
License
Original content